Dr. Olivier Gerbault's Private Practice
| フランス | トルコ | オーストリア | |
| 骨髄移植術 | から $120,000 | から $36,000 | から $140,000 |
| 非血縁者間同種骨髄移植術 | から $200,000 | から $71,500 | から $180,000 |
| 血漿交換術 | から $1,800 | から $1,200 | から $2,000 |
| 白血病化学療法 | から $15,000 | から $8,000 | から $15,000 |
| 生物学的療法 | から $15,000 | から $5,500 | から $20,000 |
Bookimedは血液腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。血液腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。血液腫瘍科治療の旅路でお一人になることはありません。
France offers elite hematology-oncology care through dedicated cancer centers and university hospitals. Gustave Roussy and the AP-HP network lead in treating leukemias and lymphomas. These facilities provide advanced cell therapies, bone marrow transplants, and clinical trials for complex blood disorders in Paris and Marseille.
Bookimed Expert Insight: Paris serves as the central hub for complex hematology, but regional centers offer comparable specialization. Patients seeking bone marrow transplants should prioritize volume-heavy centers like Institut Paoli-Calmettes in Marseille. High procedure volumes often correlate with better outcomes and more efficient cell processing protocols.
Patient Consensus: Patients emphasize choosing dedicated reference centers over general hospitals for blood cancers. They note the French system is well-organized, though securing early second opinions at major Paris hubs is highly recommended.
French oncology centers offer advanced hematology treatments including CAR T-cell therapy and allogenic bone marrow transplantation. Facilities like Institut Curie and Gustave Roussy lead in precision medicine. They utilize genome editing and antibody-drug conjugates to target metastatic cancers. These centers focus on highly specialized multidisciplinary care.
Bookimed Expert Insight: French oncology centers excel by concentrating complex cases in high-volume reference centers. Data shows these facilities manage thousands of patients annually. This volume allows them to maintain specialized platforms like Curie's CellAction for cell manufacturing. Choosing a Paris-based university hospital often grants earlier access to these proprietary clinical platforms.
Patient Consensus: Patients note that French centers are highly professional for surgical expertise and second opinions. Many emphasize that joining a clinical trial is the most reliable way to access the newest therapies early.
You can obtain a remote second opinion from a French hematologist-oncologist without immediate travel. Specialized cancer centers in France offer structured pathways for international patients. Experts review pathology reports and imaging remotely to confirm diagnoses or suggest new therapeutic strategies like CAR T-cell therapy.
Bookimed Expert Insight: French oncology centers prioritize comprehensive file reviews over simple video calls. Data shows that requesting a full pathology-slide and imaging review provides higher diagnostic accuracy than a basic consultation. This approach often identifies if specialized procedures like haploidentical stem cell transplantation are truly necessary before you book a flight.
Patient Consensus: Patients find that getting a written report first is a smart way to triage their case. They often mention it helps them decide if a physical trip is worth it or if they can stay local for their current plan.
France covers cancer and hematology treatments at 100% for residents through the Affection de Longue Durée (ALD 30) status. The state health insurance, Assurance Maladie, pays the full official tariff for hospitalizations, chemotherapy, and stem cell transplants. Residents must link this status to their Vitale card.
Bookimed Expert Insight: While the French system covers core medical costs, choosing a Sector 1 physician is a smart move for residents. Sector 1 doctors strictly follow state-negotiated rates. This ensures the 100% ALD coverage leaves you with zero out-of-pocket fees for specialized consultations in Paris or other cities.
Patient Consensus: Patients note that getting the ALD status activated by a family doctor is the most vital step. They emphasize that once registered, even expensive items like chemotherapy transport are managed without upfront payments.